Literature DB >> 12297397

Yeast-expressed Puumala hantavirus nucleocapsid protein induces protection in a bank vole model.

Ausra Dargeviciute1, Katarina Brus Sjölander, Kestutis Sasnauskas, Detlev H Krüger, Helga Meisel, Rainer Ulrich, Ake Lundkvist.   

Abstract

Hantaviruses are rodent-borne agents that cause severe human diseases. The coding sequences for the authentic and a His-tagged Puumala hantavirus (PUUV) nucleocapsid (N) protein were expressed in yeast (Saccharomyces cerevisiae). N-specific monoclonal antibodies demonstrated native antigenicity of the two proteins. All bank voles vaccinated with the His-tagged N protein in Freund's adjuvant (n=12) were defined as completely protected against subsequent virus challenge, based on the absence of viral N protein, RNA and G2-specific antibodies. In the group vaccinated with the yeast-expressed authentic N protein in Freund's adjuvant, 2/6 animals were defined as completely protected and 4/6 as partially protected. Moreover, when animals were vaccinated with the His-tagged N protein in an adjuvant certified for human use (alum), all (n=8) were at least partially protected (six completely, two partially). The general advantages of the yeast expression system make the described recombinant proteins promising candidate vaccines against hantavirus infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12297397     DOI: 10.1016/s0264-410x(02)00341-9

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  21 in total

Review 1.  Treatment of hantavirus pulmonary syndrome.

Authors:  Colleen B Jonsson; Jay Hooper; Gregory Mertz
Journal:  Antiviral Res       Date:  2007-11-21       Impact factor: 5.970

2.  Extensive host sharing of central European Tula virus.

Authors:  Jonas Schmidt-Chanasit; Sandra Essbauer; Rasa Petraityte; Kumiko Yoshimatsu; Kirsten Tackmann; Franz J Conraths; Kestutis Sasnauskas; Jiro Arikawa; Astrid Thomas; Martin Pfeffer; Jerrold J Scharninghausen; Wolf Splettstoesser; Matthias Wenk; Gerald Heckel; Rainer G Ulrich
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

3.  Identification of three novel CTL epitopes within nucleocapsid protein of Hantaan virus.

Authors:  Meiliang Wang; Yong Zhu; Jiuping Wang; Tongde Lv; Boquan Jin
Journal:  Viral Immunol       Date:  2011-11-23       Impact factor: 2.257

4.  Construction and nonclinical testing of a Puumala virus synthetic M gene-based DNA vaccine.

Authors:  R L Brocato; M J Josleyn; V Wahl-Jensen; C S Schmaljohn; J W Hooper
Journal:  Clin Vaccine Immunol       Date:  2012-12-12

5.  Nucleocapsid protein of cell culture-adapted Seoul virus strain 80-39: analysis of its encoding sequence, expression in yeast and immuno-reactivity.

Authors:  Jonas Schmidt; Burkhard Jandrig; Boris Klempa; Kumiko Yoshimatsu; Jiro Arikawa; Helga Meisel; Matthias Niedrig; Christian Pitra; Detlev H Krüger; Rainer Ulrich
Journal:  Virus Genes       Date:  2005-01       Impact factor: 2.332

6.  A new Puumala hantavirus subtype in rodents associated with an outbreak of Nephropathia epidemica in South-East Germany in 2004.

Authors:  S Essbauer; J Schmidt; F J Conraths; R Friedrich; J Koch; W Hautmann; M Pfeffer; R Wölfel; J Finke; G Dobler; R Ulrich
Journal:  Epidemiol Infect       Date:  2006-05-02       Impact factor: 2.451

7.  Profiling of external metabolites during production of hantavirus nucleocapsid protein with recombinant Saccharomyces cerevisiae.

Authors:  Linas Antoniukas; Hartmut Grammel; Kestutis Sasnauskas; Udo Reichl
Journal:  Biotechnol Lett       Date:  2007-11-06       Impact factor: 2.461

8.  Seroepidemiological study in a Puumala virus outbreak area in South-East Germany.

Authors:  Marc Mertens; Roman Wölfel; Katrin Ullrich; Kumiko Yoshimatsu; Jana Blumhardt; Ina Römer; Jutta Esser; Jonas Schmidt-Chanasit; Martin H Groschup; Gerhard Dobler; Sandra S Essbauer; Rainer G Ulrich
Journal:  Med Microbiol Immunol       Date:  2009-01-16       Impact factor: 3.402

9.  Use of Saccharomyces cerevisiae-expressed recombinant nucleocapsid protein to detect Hantaan virus-specific immunoglobulin G (IgG) and IgM in oral fluid.

Authors:  Rasa Petraityte; Li Jin; Rashpal Hunjan; Ausra Razanskiene; Aurelija Zvirbliene; Kestutis Sasnauskas
Journal:  Clin Vaccine Immunol       Date:  2007-10-03

Review 10.  Network "Rodent-borne pathogens" in Germany: longitudinal studies on the geographical distribution and prevalence of hantavirus infections.

Authors:  R G Ulrich; J Schmidt-Chanasit; M Schlegel; J Jacob; H-J Pelz; M Mertens; M Wenk; T Büchner; D Masur; K Sevke; M H Groschup; F-W Gerstengarbe; M Pfeffer; R Oehme; W Wegener; M Bemmann; L Ohlmeyer; R Wolf; H Zoller; J Koch; S Brockmann; G Heckel; S S Essbauer
Journal:  Parasitol Res       Date:  2008-11-23       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.